amyloid β aβ peptides Search Results


93
ProSci Incorporated amyloid β
Amyloid β, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/amyloid+beta+Antibody+%5B6E10%5D%2C+Mouse+IgG1/pmc12686124-161-34-39
Average 93 stars, based on 1 article reviews
amyloid β - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Biosensis ltd mouse anti moab2
Mouse Anti Moab2, supplied by Biosensis ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/Anti-Amyloid+beta+peptide+(A-beta+40-42)+Antibody/pm40233761-308-54-57
Average 94 stars, based on 1 article reviews
mouse anti moab2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
MedChemExpress basic stock solution
Basic Stock Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/%CE%B2-Amyloid/pm37402721-480-0-6
Average 93 stars, based on 1 article reviews
basic stock solution - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
StressMarq oc antiamyloid fibrils antibody
Oc Antiamyloid Fibrils Antibody, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/Anti-Amyloid+Fibrils+(OC)+Antibody/pm33318190-220-6-14
Average 93 stars, based on 1 article reviews
oc antiamyloid fibrils antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
StressMarq fibrils stressmarq biosciences spr 487
Fibrils Stressmarq Biosciences Spr 487, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/Amyloid+Beta+Protein/pm37838947-166-190-191
Average 93 stars, based on 1 article reviews
fibrils stressmarq biosciences spr 487 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

92
StressMarq fibril
Fibril, supplied by StressMarq, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/Amyloid+Beta+Pyroglutamate+3-42+Pre-formed+Fibrils/pm38516884-220-11-12
Average 92 stars, based on 1 article reviews
fibril - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

90
ProSci Incorporated anti app c
Anti App C, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/APP+Peptide/pmc04217088-325-21-48
Average 90 stars, based on 1 article reviews
anti app c - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
StressMarq oligomeric
Oligomeric, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/Amyloid+Beta+Protein/pm38516884-220-5-6
Average 93 stars, based on 1 article reviews
oligomeric - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
StressMarq monomeric
Monomeric, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/Amyloid+Beta+Protein/pm38516884-220-0-1
Average 93 stars, based on 1 article reviews
monomeric - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
GL Biochem amyloid β (aβ residues 1–42) peptides
Aβ directly interacts with <t>VDAC1</t> and enhances its channel conductance. A, VDAC1 was reconstituted into a PLB, and currents through the VDAC1 channel in response to voltage steps from 0 to −10 or +10 mV were recorded before and 5 min after the addition of Aβ (2 μm) incubated 5 days at 37 °C. A representative of three independent experiments is shown. B, the effect of Aβ (incubated 5 days at 37 °C) on VDAC1 conductance as a function of voltage from 60 mV to −60 mV was tested. The average steady-state conductance at a given voltage was normalized to the conductance at 10 mV. The recordings were taken before (●) and 5 min after (○) the addition of Aβ (2 μm). C, similar experiment as in A, except that non-incubated Aβ was used. D, similar experiment as in B, except that non-incubated Aβ was used. E, the effect of Aβ (2 μm) (incubated for 5 days at 37 °C) on the conductance of PLB, in response to voltage step from 0 to 10 mV, was tested with the currents recorded before and 15 min after the addition of Aβ. A representative of three independent experiments is shown. F, purified VDAC1 was fluorescently labeled using the NanoTemper blue protein-labeling kit according to the manufacturer's instructions. VDAC1 (100 nm) was incubated for 20 min with Aβ (1.2–100 μm), and thermophoresis was measured using the Monolith-NT115 apparatus. A Kd of 50 μm was determined. A representative of three independent experiments is shown. ΔF Norm, change in normalized fluorescence (G, similar experiment as in F was carried using a label-free MST system where intrinsic VDAC1 tryptophan fluorescence provided the analyzed signal. A Kd of 16.6 μm was determined for this interaction. A representative of three independent experiments is shown.
Amyloid β (Aβ Residues 1–42) Peptides, supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/amyloid+%CE%B2++a%CE%B2+residues+1+42++peptides/pmc04692199-182-18-29
Average 90 stars, based on 1 article reviews
amyloid β (aβ residues 1–42) peptides - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Athena Neurosciences biotin-conjugated monoclonal antibody against amyloid b protein (1–5) (3d6)
Aβ directly interacts with <t>VDAC1</t> and enhances its channel conductance. A, VDAC1 was reconstituted into a PLB, and currents through the VDAC1 channel in response to voltage steps from 0 to −10 or +10 mV were recorded before and 5 min after the addition of Aβ (2 μm) incubated 5 days at 37 °C. A representative of three independent experiments is shown. B, the effect of Aβ (incubated 5 days at 37 °C) on VDAC1 conductance as a function of voltage from 60 mV to −60 mV was tested. The average steady-state conductance at a given voltage was normalized to the conductance at 10 mV. The recordings were taken before (●) and 5 min after (○) the addition of Aβ (2 μm). C, similar experiment as in A, except that non-incubated Aβ was used. D, similar experiment as in B, except that non-incubated Aβ was used. E, the effect of Aβ (2 μm) (incubated for 5 days at 37 °C) on the conductance of PLB, in response to voltage step from 0 to 10 mV, was tested with the currents recorded before and 15 min after the addition of Aβ. A representative of three independent experiments is shown. F, purified VDAC1 was fluorescently labeled using the NanoTemper blue protein-labeling kit according to the manufacturer's instructions. VDAC1 (100 nm) was incubated for 20 min with Aβ (1.2–100 μm), and thermophoresis was measured using the Monolith-NT115 apparatus. A Kd of 50 μm was determined. A representative of three independent experiments is shown. ΔF Norm, change in normalized fluorescence (G, similar experiment as in F was carried using a label-free MST system where intrinsic VDAC1 tryptophan fluorescence provided the analyzed signal. A Kd of 16.6 μm was determined for this interaction. A representative of three independent experiments is shown.
Biotin Conjugated Monoclonal Antibody Against Amyloid B Protein (1–5) (3d6), supplied by Athena Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/beta+amyloid+peptide++a%CE%B2++antibody/10__1523_slash_jneurosci__16___18___05795__1996-70-32-41
Average 90 stars, based on 1 article reviews
biotin-conjugated monoclonal antibody against amyloid b protein (1–5) (3d6) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
AnaSpec 6-carboxyfluorescein (fam)-labeled aβ 1–42
Alcohol reduces amyloid beta phagocytosis in rat microglia. Primary rat microglia were incubated overnight with a nothing (control), b 75 mM ethanol, c TII, or d 75 mM ethanol and TII. The next day, the cells were assayed by flow cytometry for phagocytosis of FAM-labeled oligomeric Aβ 1–42 . e Average internalized FAM fluorescence per cell. Data is from 3 different batches of microglial cells totaling 9197 (controls), 8976 (alcohol), 24,588 (TII), and 28,773 (Alc * TII) events. * P < 0.005 versus control cells, one-way ANOVA, Tukey’s post hoc analysis
6 Carboxyfluorescein (Fam) Labeled Aβ 1–42, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amyloid+%CE%B2+a%CE%B2+peptides/5+carboxyfluorescein++5+fam++labeled+synthetic+human+amyloid+%CE%B2++a%CE%B2++peptide+with+amino+acids+1+42/pmc05952855-72-20-24
Average 90 stars, based on 1 article reviews
6-carboxyfluorescein (fam)-labeled aβ 1–42 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Aβ directly interacts with VDAC1 and enhances its channel conductance. A, VDAC1 was reconstituted into a PLB, and currents through the VDAC1 channel in response to voltage steps from 0 to −10 or +10 mV were recorded before and 5 min after the addition of Aβ (2 μm) incubated 5 days at 37 °C. A representative of three independent experiments is shown. B, the effect of Aβ (incubated 5 days at 37 °C) on VDAC1 conductance as a function of voltage from 60 mV to −60 mV was tested. The average steady-state conductance at a given voltage was normalized to the conductance at 10 mV. The recordings were taken before (●) and 5 min after (○) the addition of Aβ (2 μm). C, similar experiment as in A, except that non-incubated Aβ was used. D, similar experiment as in B, except that non-incubated Aβ was used. E, the effect of Aβ (2 μm) (incubated for 5 days at 37 °C) on the conductance of PLB, in response to voltage step from 0 to 10 mV, was tested with the currents recorded before and 15 min after the addition of Aβ. A representative of three independent experiments is shown. F, purified VDAC1 was fluorescently labeled using the NanoTemper blue protein-labeling kit according to the manufacturer's instructions. VDAC1 (100 nm) was incubated for 20 min with Aβ (1.2–100 μm), and thermophoresis was measured using the Monolith-NT115 apparatus. A Kd of 50 μm was determined. A representative of three independent experiments is shown. ΔF Norm, change in normalized fluorescence (G, similar experiment as in F was carried using a label-free MST system where intrinsic VDAC1 tryptophan fluorescence provided the analyzed signal. A Kd of 16.6 μm was determined for this interaction. A representative of three independent experiments is shown.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: Aβ directly interacts with VDAC1 and enhances its channel conductance. A, VDAC1 was reconstituted into a PLB, and currents through the VDAC1 channel in response to voltage steps from 0 to −10 or +10 mV were recorded before and 5 min after the addition of Aβ (2 μm) incubated 5 days at 37 °C. A representative of three independent experiments is shown. B, the effect of Aβ (incubated 5 days at 37 °C) on VDAC1 conductance as a function of voltage from 60 mV to −60 mV was tested. The average steady-state conductance at a given voltage was normalized to the conductance at 10 mV. The recordings were taken before (●) and 5 min after (○) the addition of Aβ (2 μm). C, similar experiment as in A, except that non-incubated Aβ was used. D, similar experiment as in B, except that non-incubated Aβ was used. E, the effect of Aβ (2 μm) (incubated for 5 days at 37 °C) on the conductance of PLB, in response to voltage step from 0 to 10 mV, was tested with the currents recorded before and 15 min after the addition of Aβ. A representative of three independent experiments is shown. F, purified VDAC1 was fluorescently labeled using the NanoTemper blue protein-labeling kit according to the manufacturer's instructions. VDAC1 (100 nm) was incubated for 20 min with Aβ (1.2–100 μm), and thermophoresis was measured using the Monolith-NT115 apparatus. A Kd of 50 μm was determined. A representative of three independent experiments is shown. ΔF Norm, change in normalized fluorescence (G, similar experiment as in F was carried using a label-free MST system where intrinsic VDAC1 tryptophan fluorescence provided the analyzed signal. A Kd of 16.6 μm was determined for this interaction. A representative of three independent experiments is shown.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Incubation, Purification, Labeling, Fluorescence

Aβ interacts with VDAC1-based peptides. A, VDAC1 N-Ter peptide interaction with Aβ, as analyzed by SPR. Aβ, immobilized onto a GLC sensor surface, was exposed to the VDAC1 N-Ter peptide (0–400 μm), and the interaction was monitored using the ProteOn imaging system and related software tools. The two lines of each color represent the obtained results and fitted curves. B, Aβ interaction with the VDAC1 N-Ter peptide as analyzed using the heterogeneous ligand interaction model, where one analyte binds two different ligand species, yielding a Kd1 value of 2.5 μm and a Kd2 value of 900 μm. RU, response units.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: Aβ interacts with VDAC1-based peptides. A, VDAC1 N-Ter peptide interaction with Aβ, as analyzed by SPR. Aβ, immobilized onto a GLC sensor surface, was exposed to the VDAC1 N-Ter peptide (0–400 μm), and the interaction was monitored using the ProteOn imaging system and related software tools. The two lines of each color represent the obtained results and fitted curves. B, Aβ interaction with the VDAC1 N-Ter peptide as analyzed using the heterogeneous ligand interaction model, where one analyte binds two different ligand species, yielding a Kd1 value of 2.5 μm and a Kd2 value of 900 μm. RU, response units.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Imaging, Software

The VDAC1 N-Ter peptide prevents Aβ from binding and entering cells and protects against Aβ-induced apoptosis. A, PC12 cells were treated with different concentrations of Aβ with (●) or without (○) the VDAC1 N-Ter peptide (20 μm) for 48 h, when cell viability was assessed by the XTT assay. A representative of three independent experiments is presented. B, PC12 cells were treated with different concentrations of the VDAC1 N-Ter peptide and a constant concentration (30 μm) of Aβ for 48 h when cell viability was assessed by the XTT assay. A representative of three independent experiments is presented. C, the VDAC1 N-Ter peptide protects against Aβ-induced apoptosis in SH-SY5Y cells. SH-SY5Y cells were incubated with Aβ (10, 20 μm) in the absence or presence of the VDAC1 N-Ter peptide (20 μm) for 48 h, when aliquots were stained with acridine orange and ethidium bromide as described (30). Confocal images are shown, with early apoptotic stage cells reflected by membrane blebbing (arrows). Late apoptotic stage is indicated by arrowheads. Bar = 10 μm. D, quantification of the results obtained in C. The analysis was carried out by counting live and late apoptotic cells from a total of 120 to 160 cells in each sample.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: The VDAC1 N-Ter peptide prevents Aβ from binding and entering cells and protects against Aβ-induced apoptosis. A, PC12 cells were treated with different concentrations of Aβ with (●) or without (○) the VDAC1 N-Ter peptide (20 μm) for 48 h, when cell viability was assessed by the XTT assay. A representative of three independent experiments is presented. B, PC12 cells were treated with different concentrations of the VDAC1 N-Ter peptide and a constant concentration (30 μm) of Aβ for 48 h when cell viability was assessed by the XTT assay. A representative of three independent experiments is presented. C, the VDAC1 N-Ter peptide protects against Aβ-induced apoptosis in SH-SY5Y cells. SH-SY5Y cells were incubated with Aβ (10, 20 μm) in the absence or presence of the VDAC1 N-Ter peptide (20 μm) for 48 h, when aliquots were stained with acridine orange and ethidium bromide as described (30). Confocal images are shown, with early apoptotic stage cells reflected by membrane blebbing (arrows). Late apoptotic stage is indicated by arrowheads. Bar = 10 μm. D, quantification of the results obtained in C. The analysis was carried out by counting live and late apoptotic cells from a total of 120 to 160 cells in each sample.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Binding Assay, XTT Assay, Concentration Assay, Incubation, Staining, Membrane

Cells incubated with N-terminal peptide show decreased Aβ cell penetration. SH-SY5Y cells were incubated with Aβ (10 μm) in the absence or presence of the VDAC1 N-Ter peptide (20 μm) for 6 h, then cells were fixed and incubated with anti-Aβ antibodies followed by secondary Cy3-conjugated anti-rabbit antibodies (shown in red) and anti-Cyto c antibodies followed by secondary Cy2 conjugated anti-mouse antibodies (shown in green). Cells were also stained with DAPI (blue) and visualized by confocal microscopy. The VDAC1 N-Ter peptide significantly reduced Aβ attachment and cell entry. The third and fifth columns represent enlargements of the marked areas. Bar = 10 μm.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: Cells incubated with N-terminal peptide show decreased Aβ cell penetration. SH-SY5Y cells were incubated with Aβ (10 μm) in the absence or presence of the VDAC1 N-Ter peptide (20 μm) for 6 h, then cells were fixed and incubated with anti-Aβ antibodies followed by secondary Cy3-conjugated anti-rabbit antibodies (shown in red) and anti-Cyto c antibodies followed by secondary Cy2 conjugated anti-mouse antibodies (shown in green). Cells were also stained with DAPI (blue) and visualized by confocal microscopy. The VDAC1 N-Ter peptide significantly reduced Aβ attachment and cell entry. The third and fifth columns represent enlargements of the marked areas. Bar = 10 μm.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Incubation, Staining, Confocal Microscopy

Cells with low levels of VDAC1 show decreased Aβ cell penetration and cytotoxicity. SH-SY5Y cells were transfected with VDAC1-siRNA (50 nm) or not transfected, and 24 h later the cells were incubated with 20 μm Aβ for 48 h. A and B, SH-SY5Y cells transfected with 50 nm of scrambled (Scr) siRNA or VDAC1-siRNA, and 24 h post-transfection cells were treated with different concentrations of Aβ for 48 h. A, cell viability was assessed by the XTT assay for (Scr) siRNA (●)- or VDAC1-siRNA (○)-treated cells The data represent the mean ± S.D. (n = 3). The inset shows Western blot analysis of VDAC1 protein levels in SH-SY5Y cells transfected with Scr- or VDAC1-siRNA. RU indicates relative units, showing a decrease of 74% in VDAC1 level in cells treated with VDAC1-siRNA. B, a similar experiment as in A was carried out, and cell death rate was determined using propidium iodide staining for Scr-siRNA (black)- or VDAC1-siRNA (gray)-treated cells.). C, cells were fixed and incubated with anti-Aβ antibodies followed by secondary Cy3-conjugated anti-rabbit antibodies (shown in red) and anti-Cyto c antibodies followed by secondary Cy2 conjugated anti-mouse antibodies (shown in green). Cells were also stained with DAPI (blue) and visualized by confocal microscopy. The third and fifth columns represent enlargements of the marked areas. Bar = 10 μm. The lack of Aβ staining in siRNA-treated cells may indicate the Aβ inability of to cross the cell membrane.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: Cells with low levels of VDAC1 show decreased Aβ cell penetration and cytotoxicity. SH-SY5Y cells were transfected with VDAC1-siRNA (50 nm) or not transfected, and 24 h later the cells were incubated with 20 μm Aβ for 48 h. A and B, SH-SY5Y cells transfected with 50 nm of scrambled (Scr) siRNA or VDAC1-siRNA, and 24 h post-transfection cells were treated with different concentrations of Aβ for 48 h. A, cell viability was assessed by the XTT assay for (Scr) siRNA (●)- or VDAC1-siRNA (○)-treated cells The data represent the mean ± S.D. (n = 3). The inset shows Western blot analysis of VDAC1 protein levels in SH-SY5Y cells transfected with Scr- or VDAC1-siRNA. RU indicates relative units, showing a decrease of 74% in VDAC1 level in cells treated with VDAC1-siRNA. B, a similar experiment as in A was carried out, and cell death rate was determined using propidium iodide staining for Scr-siRNA (black)- or VDAC1-siRNA (gray)-treated cells.). C, cells were fixed and incubated with anti-Aβ antibodies followed by secondary Cy3-conjugated anti-rabbit antibodies (shown in red) and anti-Cyto c antibodies followed by secondary Cy2 conjugated anti-mouse antibodies (shown in green). Cells were also stained with DAPI (blue) and visualized by confocal microscopy. The third and fifth columns represent enlargements of the marked areas. Bar = 10 μm. The lack of Aβ staining in siRNA-treated cells may indicate the Aβ inability of to cross the cell membrane.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Transfection, Incubation, XTT Assay, Western Blot, Staining, Confocal Microscopy, Membrane

VDAC1 targeted to the plasma membrane induces cell death and enhances Aβ-mediated apoptosis. A, SH-SY5Y cells were transfected with an mVDAC1-GFP-CAAX-encoding plasmid (green). Forty-eight hours later, the cells were fixed, and the nuclei were stained with DAPI (blue) and visualized by confocal microscopy. Bar = 20 μm. B, enlargement of the marked area in A. C–F, SH-SY5Y cells were transfected with an empty plasmid or a mVDAC1-CAAX-expressing plasmid. Twenty-four hours later, the cells were incubated for 48 h with or without Aβ, then cells were stained with propidium iodide (PI) and analyzed by flow cytometry using ec800 software. C, Western blot analysis of VDAC1 protein levels in SH-SY5Y cells transfected with plasmid mVDAC1-CAAX using long and low exposure times. Arrows indicate exogenous and mVDAC1-CAAX-fused proteins. D and E, representative flow cytometry results for control and mVDAC1-CAAX-expressing cells are shown. F, quantitation of the FACS analysis of apoptosis induced by incubation with Aβ (5 and 10 μm) of cells transfected with the empty plasmid (gray) or the mVDAC1-CAAX plasmid (black).

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: VDAC1 targeted to the plasma membrane induces cell death and enhances Aβ-mediated apoptosis. A, SH-SY5Y cells were transfected with an mVDAC1-GFP-CAAX-encoding plasmid (green). Forty-eight hours later, the cells were fixed, and the nuclei were stained with DAPI (blue) and visualized by confocal microscopy. Bar = 20 μm. B, enlargement of the marked area in A. C–F, SH-SY5Y cells were transfected with an empty plasmid or a mVDAC1-CAAX-expressing plasmid. Twenty-four hours later, the cells were incubated for 48 h with or without Aβ, then cells were stained with propidium iodide (PI) and analyzed by flow cytometry using ec800 software. C, Western blot analysis of VDAC1 protein levels in SH-SY5Y cells transfected with plasmid mVDAC1-CAAX using long and low exposure times. Arrows indicate exogenous and mVDAC1-CAAX-fused proteins. D and E, representative flow cytometry results for control and mVDAC1-CAAX-expressing cells are shown. F, quantitation of the FACS analysis of apoptosis induced by incubation with Aβ (5 and 10 μm) of cells transfected with the empty plasmid (gray) or the mVDAC1-CAAX plasmid (black).

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Clinical Proteomics, Membrane, Transfection, Plasmid Preparation, Staining, Confocal Microscopy, Expressing, Incubation, Flow Cytometry, Software, Western Blot, Control, Quantitation Assay

Aβ induces hexokinase detachment, VDAC1 oligomerization, and cytochrome c release. A, SH-SY5Y cells were transfected to express HK-I-GFP (green). Twenty-four hours later the cells were incubated without (Aa) or with Aβ (5 μm (Ab) or 10 μm (Ac)) for 16 h. The cells were then fixed and stained with DAPI (blue). Mitochondrial-bound HK-I-GFP (Aa, arrows) and detached, cytosolic HK-I-GFP (A, b and c, arrowheads), are indicated. Red arrows indicate fragmented nuclei presenting Aβ-induced apoptosis. Scale bar = 20 μm. B and C, Aβ-induced VDAC1 oligomerization, SH-SY5Y (B) and HeLa (C) cells were incubated without or with Aβ (5 μm or 10 μm). Forty-eight hours later the cells were analyzed for VDAC1 oligomerization as revealed by EGS-based cross-linking and immunoblotting using anti-VDAC1 antibodies. Quantitative analysis of the level of VDAC1 dimers relative to actin is presented in relative unit. D and E, SH-SY5Y cells were incubated with or without Aβ (5 or 10 μm) for 48 h and analyzed for cytochrome c release using anti-cytochrome c-specific antibodies. SH-SY5Y cells were treated with digitonin (0.0015%), and release of Cyto c from mitochondria (Mito) to the cytosolic fraction (Cyto) was analyzed by immunoblotting (D) as described under “Experimental Procedures.” Anti-ATP synthase 5a (ATPsyn5a) antibodies were used to demonstrate the absence of mitochondria in the cytosolic fraction. Cytochrome c release was also analyzed by immunocytochemistry using anti-cytochrome c-specific antibodies. Cells were also stained with DAPI (blue) and visualized by confocal microscopy (E). Cytochrome c staining is significantly reduced in the Aβ-treated cells (Eb and Ec) as compared with the control cells (Ea). Scale bars = 10 μm. RU, relative units.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: Aβ induces hexokinase detachment, VDAC1 oligomerization, and cytochrome c release. A, SH-SY5Y cells were transfected to express HK-I-GFP (green). Twenty-four hours later the cells were incubated without (Aa) or with Aβ (5 μm (Ab) or 10 μm (Ac)) for 16 h. The cells were then fixed and stained with DAPI (blue). Mitochondrial-bound HK-I-GFP (Aa, arrows) and detached, cytosolic HK-I-GFP (A, b and c, arrowheads), are indicated. Red arrows indicate fragmented nuclei presenting Aβ-induced apoptosis. Scale bar = 20 μm. B and C, Aβ-induced VDAC1 oligomerization, SH-SY5Y (B) and HeLa (C) cells were incubated without or with Aβ (5 μm or 10 μm). Forty-eight hours later the cells were analyzed for VDAC1 oligomerization as revealed by EGS-based cross-linking and immunoblotting using anti-VDAC1 antibodies. Quantitative analysis of the level of VDAC1 dimers relative to actin is presented in relative unit. D and E, SH-SY5Y cells were incubated with or without Aβ (5 or 10 μm) for 48 h and analyzed for cytochrome c release using anti-cytochrome c-specific antibodies. SH-SY5Y cells were treated with digitonin (0.0015%), and release of Cyto c from mitochondria (Mito) to the cytosolic fraction (Cyto) was analyzed by immunoblotting (D) as described under “Experimental Procedures.” Anti-ATP synthase 5a (ATPsyn5a) antibodies were used to demonstrate the absence of mitochondria in the cytosolic fraction. Cytochrome c release was also analyzed by immunocytochemistry using anti-cytochrome c-specific antibodies. Cells were also stained with DAPI (blue) and visualized by confocal microscopy (E). Cytochrome c staining is significantly reduced in the Aβ-treated cells (Eb and Ec) as compared with the control cells (Ea). Scale bars = 10 μm. RU, relative units.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Transfection, Incubation, Staining, Western Blot, Immunocytochemistry, Confocal Microscopy, Control

Model describing how Aβ leads to mitochondria-mediated cell death. A, molecular dynamics simulation of the interaction between monomeric Aβ peptide (Gly-29–Ala-42) and the N-terminal domain of VDAC1 (Met-1–Gly-26) identifies two sites of interactions, one of which is the GXXXG motif. B, Aβ peptide (Leu-17–Ala-42 and VDAC1 possibly interact through electrostatic (negative charges in Aβ and positive charges in N-terminal domain of VDAC1 are presented by red and blue colors, respectively), hydrophobic, and/or via GXXXG motif interactions. The GXXXG motif in VDAC1 and the Aβ oligomers are colored green. C, proposed model for Aβ cell penetration and apoptosis induction. Monomeric Aβ can form protofibrils and soluble aggregates. Based on our results, we suggest that VDAC1 plays a key role in Aβ toxicity on several levels. In the plasma membrane, plVDAC1 interacts with Aβ oligomers via its N-terminal domain, leading to VDAC1 oligomerization and the formation of large pores composed of Aβ-VDAC1 heteromers. These large pores allow Aβ to enter the cell and interact with mitochondrial VDAC1, leading to detachment of VDAC1-bound HK-I and VDAC1 oligomerization, concomitant with the formation of heteromeric Aβ-VDAC1 large pores that allow release of Cyto c, and the subsequent induction of apoptosis. Non-membrane-penetrating VDAC1 N-Ter peptides inhibit Aβ cell entry, probably by interacting with Aβ, thus sequestering and preventing Aβ interacting with plVDAC1 and entering the cell to elicit a toxic effect. D, proposed model for VDAC1-based treatment in Alzheimer disease. VDAC1 is overexpressed in Alzheimer disease, leading to VDAC1 oligomerization and subsequent Cyto c release and apoptosis. This VDAC1-dependent apoptosis can be inhibited by preventing VDAC1 expression by VDAC1-siRNA or inhibiting VDAC1 oligomerization stimulated by Aβ by VDAC1-N-Ter peptide.

Journal: The Journal of Biological Chemistry

Article Title: The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy *

doi: 10.1074/jbc.M115.691493

Figure Lengend Snippet: Model describing how Aβ leads to mitochondria-mediated cell death. A, molecular dynamics simulation of the interaction between monomeric Aβ peptide (Gly-29–Ala-42) and the N-terminal domain of VDAC1 (Met-1–Gly-26) identifies two sites of interactions, one of which is the GXXXG motif. B, Aβ peptide (Leu-17–Ala-42 and VDAC1 possibly interact through electrostatic (negative charges in Aβ and positive charges in N-terminal domain of VDAC1 are presented by red and blue colors, respectively), hydrophobic, and/or via GXXXG motif interactions. The GXXXG motif in VDAC1 and the Aβ oligomers are colored green. C, proposed model for Aβ cell penetration and apoptosis induction. Monomeric Aβ can form protofibrils and soluble aggregates. Based on our results, we suggest that VDAC1 plays a key role in Aβ toxicity on several levels. In the plasma membrane, plVDAC1 interacts with Aβ oligomers via its N-terminal domain, leading to VDAC1 oligomerization and the formation of large pores composed of Aβ-VDAC1 heteromers. These large pores allow Aβ to enter the cell and interact with mitochondrial VDAC1, leading to detachment of VDAC1-bound HK-I and VDAC1 oligomerization, concomitant with the formation of heteromeric Aβ-VDAC1 large pores that allow release of Cyto c, and the subsequent induction of apoptosis. Non-membrane-penetrating VDAC1 N-Ter peptides inhibit Aβ cell entry, probably by interacting with Aβ, thus sequestering and preventing Aβ interacting with plVDAC1 and entering the cell to elicit a toxic effect. D, proposed model for VDAC1-based treatment in Alzheimer disease. VDAC1 is overexpressed in Alzheimer disease, leading to VDAC1 oligomerization and subsequent Cyto c release and apoptosis. This VDAC1-dependent apoptosis can be inhibited by preventing VDAC1 expression by VDAC1-siRNA or inhibiting VDAC1 oligomerization stimulated by Aβ by VDAC1-N-Ter peptide.

Article Snippet: Celluspots peptide arrays were obtained from INTAVIS Bioanalytical Instruments (Koln, Germany). . Amyloid β (Aβ residues 1–42) and VDAC1 N-terminal ( 1 MAVPPTYADLGKSARDVFTKGYGFGL 26 ) peptides were synthesized by GL Biochem (Shanghai, China).

Techniques: Clinical Proteomics, Membrane, Expressing

Alcohol reduces amyloid beta phagocytosis in rat microglia. Primary rat microglia were incubated overnight with a nothing (control), b 75 mM ethanol, c TII, or d 75 mM ethanol and TII. The next day, the cells were assayed by flow cytometry for phagocytosis of FAM-labeled oligomeric Aβ 1–42 . e Average internalized FAM fluorescence per cell. Data is from 3 different batches of microglial cells totaling 9197 (controls), 8976 (alcohol), 24,588 (TII), and 28,773 (Alc * TII) events. * P < 0.005 versus control cells, one-way ANOVA, Tukey’s post hoc analysis

Journal: Journal of Neuroinflammation

Article Title: Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis

doi: 10.1186/s12974-018-1184-7

Figure Lengend Snippet: Alcohol reduces amyloid beta phagocytosis in rat microglia. Primary rat microglia were incubated overnight with a nothing (control), b 75 mM ethanol, c TII, or d 75 mM ethanol and TII. The next day, the cells were assayed by flow cytometry for phagocytosis of FAM-labeled oligomeric Aβ 1–42 . e Average internalized FAM fluorescence per cell. Data is from 3 different batches of microglial cells totaling 9197 (controls), 8976 (alcohol), 24,588 (TII), and 28,773 (Alc * TII) events. * P < 0.005 versus control cells, one-way ANOVA, Tukey’s post hoc analysis

Article Snippet: After 24 h, the medium was replaced with fresh medium (control or containing 75 mM EtOH) supplemented with 6-carboxyfluorescein (FAM)-labeled Aβ 1–42 (0.5 μM; Anaspec, Fremont, CA, USA).

Techniques: Incubation, Flow Cytometry, Labeling, Fluorescence